DUAL EFFECTS OF INTERLEUKIN-4 ON ANTIGEN-ACTIVATED HUMAN-B CELLS - INDUCTION OF PROLIFERATION AND INHIBITION OF INTERLEUKIN 2-DEPENDENT DIFFERENTIATION

被引:20
作者
LLORENTE, L
MITJAVILA, F
CREVON, MC
GALANAUD, P
机构
[1] ASSOC CLAUDE BERNARD, INSERM, U131, 32 RUE CARNETS, F-92140 CLAMART, FRANCE
[2] ASSOC CLAUDE BERNARD, F-92140 CLAMART, FRANCE
关键词
D O I
10.1002/eji.1830200903
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We analyzed the effects of interleukin 2 (IL 2) and IL 4 isolated and in association on the specific response of human B cells triggered by trinitrophenylated polyacrylamide beads (TNP‐PAA). IL 2 induced an increase (more than 10 times) in the number of hapten‐binding cells [detected by a rosette‐forming cell (RFC) assay] as well as the generation of antibody‐producing cells [detected by a plaque‐forming cell (PFC) assay]. IL 4 induced an isolated RFC response without PFC response. We verified that the IL 4 (as well as I2)‐induced RFC were hapten specific and mediated through membrane IgM. Density fractionation experiments showed that IL 4‐induced RFC were equally distributed between highdensity and intermediate‐density B cells. IL 2 appeared to drive more B cells into the intermediate density fraction. IL 2‐induced PFC belonged to the RFC population and were intermediate‐size B cells. IL 2 drove more RFC into an activated stage and it induced the differentiation of a number of them into antibody‐producing cells. The evaluation of the proportion of RFC able to incorporate thymidine showed that both IL induced a substantial proliferation of antigen‐activated B cells. However, IL 4 inhibited the IL 2‐dependent PFC without affecting the number of RFC nor the proportion of proliferating RFC induced by this IL. These results directly demonstrate that human IL 4 triggers the expansion of antigen‐activated B cells and selectively inhibits the IL 2‐induced differentiation. Copyright © 1990 Wiley‐VCH Verlag GmbH & Co. KGaA
引用
收藏
页码:1887 / 1892
页数:6
相关论文
共 40 条
[31]  
SHIELDS JG, 1989, IMMUNOLOGY, V66, P224
[32]  
SNOW EC, 1983, J IMMUNOL, V130, P607
[33]  
SPITS H, 1987, J IMMUNOL, V139, P1142
[34]  
SPLAWSKI JB, 1989, J IMMUNOL, V142, P1569
[35]  
TERANISHI T, 1984, J IMMUNOL, V133, P3062
[36]   EXPRESSION OF TAC ANTIGEN ON ACTIVATED NORMAL HUMAN B-CELLS [J].
TSUDO, M ;
UCHIYAMA, T ;
UCHINO, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (02) :612-617
[37]   DIFFERENTIATION FACTORS FOR HUMAN SPECIFIC B-CELL RESPONSE [J].
VAZQUEZ, A ;
GERARD, JP ;
DELFRAISSY, JF ;
DUGAS, B ;
AUFFREDOU, MT ;
CREVON, MC ;
FRADELIZI, D ;
GALANAUD, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (07) :803-808
[38]  
VAZQUEZ A, 1989, J IMMUNOL, V142, P94
[39]   EXPRESSION OF INTERLEUKIN-2 RECEPTORS ON ACTIVATED HUMAN B-CELLS [J].
WALDMANN, TA ;
GOLDMAN, CK ;
ROBB, RJ ;
DEPPER, JM ;
LEONARD, WJ ;
SHARROW, SO ;
BONGIOVANNI, KF ;
KORSMEYER, SJ ;
GREENE, WC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (05) :1450-1466
[40]   ISOLATION AND CHARACTERIZATION OF A HUMAN INTERLEUKIN CDNA CLONE, HOMOLOGOUS TO MOUSE B-CELL STIMULATORY FACTOR-I, THAT EXPRESSES B-CELL-STIMULATING AND T-CELL-STIMULATING ACTIVITIES [J].
YOKOTA, T ;
OTSUKA, T ;
MOSMANN, T ;
BANCHEREAU, J ;
DEFRANCE, T ;
BLANCHARD, D ;
DEVRIES, JE ;
LEE, F ;
ARAI, KI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (16) :5894-5898